FIELD: chemistry.
SUBSTANCE: invention relates to peptide compound Ra-R1-R2-R3-R4-Rb (I) or Ra-R4-R3-R2-R1-Rb (II), where Ra is N-end primary amine group of amino acid R1 or R4, or free, or substituted with an amino protective group, Rb is a hydroxyl group of C-end carboxyl group of amino acid R1 or R4, or free, or substituted with hydroxy protective group, and R1-R2-R3-R4 or R4-R3-R2-R1 represent HADD, KADD, DDAK, RADD, DDAR, KAED, NEAR, 5, DEAR, HADE, EDAH, KADE, EDAK, HAMBURG, EDAR, HAEE, EEAH, KAEE, EEAK, WEEE and EEAR. Present invention also relates to use of said useful peptide compounds, in particular, for binding with β-amyloid peptides and inhibiting polymerisation in form of amyloid plaques.
EFFECT: compounds can be used as a drug or for preparing or determining preparations for treating neurodegenerative diseases, particularly Alzheimer's disease.
21 cl, 9 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION BASED ON HAEE PEPTIDE FOR TREATING NEURODEGENERATIVE DISEASES | 2019 |
|
RU2709539C1 |
METHOD FOR TREATING NEURODEGENERATIVE DISEASES | 2021 |
|
RU2777871C1 |
PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679059C1 |
PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679080C1 |
AC-HIS-ALA-GLU-GLU-NH PEPTIDE PRODUCTION METHOD | 2021 |
|
RU2767030C1 |
HAEE PEPTIDE MAGNESIUM COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784746C1 |
HAEE PEPTIDE ZINC COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784319C1 |
HAEE PEPTIDE COPPER COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2784732C1 |
PEPTIDE CALCIUM COMPLEX FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | 2022 |
|
RU2785354C1 |
HAEE SYNTHETIC TETRAPEPTIDE AND DERIVATIVES THEREOF INTENDED FOR HUMAN NEURON FUNCTION RECOVERY | 2023 |
|
RU2822603C1 |
Authors
Dates
2016-06-27—Published
2011-10-24—Filed